In-transit sentinel nodes must be found: Implication from a 10-year follow-up study in melanoma

Melanoma Research

Volumn 18, Issue 5, 2008, Pages 359-364

  Chakera, Annette H ^a   Hansen, Lone B ^a   Lock Andersen, Jørgen ^a   Drzewiecki, Krzysztof T ^a   Hesse, Birger ^a  

^a International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

Melanoma; Radionuclide imaging; Recurrence; Sentinel lymph node biopsy; survival

Indexed keywords

RHENIUM TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HIGH RISK PATIENT; HUMAN; IN-TRANSIT METASTASIS; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; MELANOMA; PREOPERATIVE EVALUATION; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; REGIONAL METASTASIS; SENTINEL LYMPH NODE; TUMOR LOCALIZATION; TUMOR VOLUME; ULCER;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 53549103572     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/CMR.0b013e328308da77     Document Type: Article

References (21)

1. McMasters KM, Chao C, Wong SL, Wrightson WR, Ross Ml, Reintgen DS, et al.; Sunbelt Melanoma Trial Group. Interval sentinel lymph nodes in melanoma. Arch Surg 2002; 137:543-549.
2. O'Toole GA, Hettiaratchy S, Allan R, Powell BWEM. Aberrant sentinel nodes in malignant melanoma. Br J Plast Surg 2000; 53 :415-417.
3. Statius Muller MG, Hennipman FA, Van Leeuwen PAM, Pijpers R, Vuylsteke RJCLM, Meijer S. Unpredictability of lymphatic drainage patterns in melanoma patients. Eur J Nucl Med 2002; 29:255-261.
4. Thompson JF. The Sydney Melanoma Unit experience of sentinel lymphadenectomy for melanoma. Ann Surg Oncol 2001; 8:44S-46S.
5. Uren RF, Howman-Giles R, Thompson JF, McCarthy WH, Quinn MJ, Roberts JM, et al. Interval nodes. The forgotten sentinel nodes in patients with melanoma. Arch Surg 2000; 135:1168-1172.
6. Lock-Andersen J, Rossing N, Drzewiecki KT Preoperative cutaneous lymphoscintigraphy in malignant melanoma. Cancer 1989; 63:77-82.
7. Caracò C, Marone U, Celentano E, Botti G, Mozzillo N. Impact of false-negative sentinel lymph node biopsy on survival in patients with cutaneous melanoma. Ann Surg Oncol 2007; 14:2662-2667.
8. Uren RF, Howman-Giles RB, Shaw HM, Thompson JF, McCarthy WH. Lymphoscintigraphy in high-risk melanoma of the trunk: predicting draining node groups, defining lymphatic channels and locating the sentinel node. J Nucl Med 1993; 34:1435-1440.
9. O'Brien CJ, Uren RF, Thompson JF, Howman-Giles RB, Petersen-Schaefer K, Shaw HM, et al. Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy. Am J Surg 1995; 170:461-466.
10. Vidal-Sicart S, Pons F, Piulachs J, Castel T, Palou J, Herranz R. Midarm sentinel lymph nodes showing surprising drainage from a malignant melanoma in the forearm. Clin Nucl Med 1998; 23:273-274.
11. Hunt JA, Thompson JF, Uren RF, Howman-Riles R, Harman CR. Epitrochlear lymph nodes as a site of melanoma metastasis. Ann Surg Oncol 1998; 5:248-252.
12. Thompson JF, Hunt JA, Culjak G, Uren RF, Howman-Giles R, Harman CR. Popliteal lymph node metastasis from primary cutaneous melanoma. Eur J Surg Oncol 2000; 26:172-176.
13. Vidal-Sicart S, Pons F, Fuertes S, Vilalta A, Rull R, Puig S, et al. Is the identification of in-transit sentinel lymph nodes in malignant melanoma patients really necessary? Eur J Nucl Med Mol Imaging 2004; 31:945-949.
14. Sumner WE III, Ross Ml, Mansfield PF, Lee JE, Prieto VG, Schacherer CW, Gershenwald JE. Implications of lymphatic drainage to unusual sentinel lymph node sites in patients with primary cutaneous melanoma. Cancer 2002; 95:354-360.
15. Roozendaal GK, De Vries JD, Van Poll D, Jansen L, Schraffordt Koops H, Nieweg OE, Kroon BB. Sentinel nodes outside lymph node basins in patients with melanoma. Br J Surg 2001; 88:305-308.
16. Thelmo MC, Morita ET, Treseler PA, Nguyen LH, Allen RE Jr, Sagebiel RW, et al. Micrometastasis to in-transit lymph nodes from extremity and truncal malignant melanoma. Ann Surg Oncol 2001; 8:444-448.
17. Gershenwald JE, Thompson W, Mansfield PF, Lee JE, Colome Ml, Tseng CH, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999; 17:976-983.
18. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. Clin Oncol 2001; 19:3635-3648.
19. Uren RF, Howman-Giles R, Thompson JF. Patterns of lymphatic drainage from the skin in patients with melanoma. J Nucl Med 2003; 44:570-582.
20. Matter M, Nicod Lalonde M, Allaoua M, Boubaker A, Liénard D, Gugerli O, et al. The role of interval nodes in sentinel lymph node mapping and dissection for melanoma patients. J Nucl Med 2007; 48:1607-1613.
21. Porter GA, Ross Ml, Berman RS, Lee JE, Mansfield PF, Gershenwald JE. Significance of multiple nodal basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsy. Ann Surg Oncol 2000; 7:256-261.